(S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of NID1 mRNA CTD PMID:25729387 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE increases expression EXP 6480464 Topotecan results in increased expression of NID1 mRNA CTD PMID:25729387 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of NID1 mRNA CTD PMID:21983209 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of NID1 mRNA CTD PMID:25380136 13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE multiple interactions ISO RGD:737172 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NID1 mRNA CTD PMID:19074003 17beta-estradiol multiple interactions ISO RGD:737172 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of NID1 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737173 6480464 Tetrachlorodibenzodioxin results in increased expression of NID1 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:737173 6480464 Tetrachlorodibenzodioxin affects the expression of NID1 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737172 6480464 Tetrachlorodibenzodioxin results in decreased expression of NID1 mRNA CTD PMID:20106945 , PMID:21632981 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of NID1 mRNA CTD PMID:25380136 4-hydroxyphenyl retinamide decreases expression ISO RGD:737173 6480464 Fenretinide results in decreased expression of NID1 mRNA CTD PMID:28973697 4-nonylphenol multiple interactions ISO RGD:737172 6480464 [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of NID1 mRNA CTD PMID:23626723 4-tert-Octylphenol multiple interactions ISO RGD:737172 6480464 [4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of NID1 mRNA CTD PMID:23626723 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of NID1 mRNA CTD PMID:24780913 7,12-dimethyltetraphene affects expression ISO RGD:737173 6480464 9 more ... CTD PMID:21785161 7,12-dimethyltetraphene decreases expression EXP 6480464 9 more ... CTD PMID:19480007 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of NID1 mRNA CTD PMID:28959563 actinonin multiple interactions ISO RGD:737173 6480464 actinonin inhibits the reaction [Cisplatin results in increased cleavage of NID1 protein] CTD PMID:25957482 all-trans-retinoic acid increases expression ISO RGD:737172 6480464 Tretinoin results in increased expression of NID1 mRNA CTD PMID:17138961 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NID1 mRNA CTD PMID:16483693 Aroclor 1254 decreases expression ISO RGD:737173 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of NID1 mRNA CTD PMID:23650126 arsane affects expression ISO RGD:737172 6480464 Arsenic affects the expression of NID1 protein CTD PMID:24675094 arsenic atom affects expression ISO RGD:737172 6480464 Arsenic affects the expression of NID1 protein CTD PMID:24675094 arsenic(3+) affects expression ISO RGD:737172 6480464 Arsenic affects the expression of NID1 protein CTD PMID:24675094 atrazine increases expression ISO RGD:737172 6480464 Atrazine results in increased expression of NID1 mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:737173 6480464 Benzo(a)pyrene results in decreased expression of NID1 mRNA CTD PMID:19770486 bilirubin IXalpha decreases expression ISO RGD:737172 6480464 Bilirubin results in decreased expression of NID1 mRNA CTD PMID:20196124 bis(2-chloroethyl) sulfide decreases expression ISO RGD:737173 6480464 Mustard Gas results in decreased expression of NID1 mRNA CTD PMID:15674843 bisphenol A decreases expression ISO RGD:737173 6480464 bisphenol A results in decreased expression of NID1 mRNA CTD PMID:22687993 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NID1 mRNA CTD PMID:25181051 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of NID1 mRNA CTD PMID:24136188 cadmium atom multiple interactions ISO RGD:737172 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NID1 mRNA CTD PMID:29741670 cadmium dichloride multiple interactions ISO RGD:737172 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NID1 mRNA CTD PMID:29741670 carbamazepine affects expression ISO RGD:737172 6480464 Carbamazepine affects the expression of NID1 mRNA CTD PMID:25979313 carbon nanotube affects expression ISO RGD:737173 6480464 Nanotubes, Carbon affects the expression of NID1 protein CTD PMID:21135415 carbon nanotube increases expression ISO RGD:737173 6480464 Nanotubes, Carbon analog results in increased expression of NID1 mRNA, Nanotubes, Carbon results in increased expression of NID1 mRNA CTD PMID:25554681 choline multiple interactions ISO RGD:737173 6480464 [Dietary Fats co-treated with Choline deficiency] results in increased expression of NID1 mRNA more ... CTD PMID:20938992 , PMID:29246445 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of NID1 mRNA CTD PMID:22023808 cisplatin multiple interactions ISO RGD:737172 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of NID1 mRNA CTD PMID:27392435 cisplatin increases expression ISO RGD:737172 6480464 Cisplatin results in increased expression of NID1 mRNA CTD PMID:27392435 cisplatin increases cleavage ISO RGD:737173 6480464 Cisplatin results in increased cleavage of NID1 protein CTD PMID:25957482 cisplatin multiple interactions ISO RGD:737173 6480464 actinonin inhibits the reaction [Cisplatin results in increased cleavage of NID1 protein], MEP1B gene mutant form inhibits the reaction [Cisplatin results in increased cleavage of NID1 protein] CTD PMID:25957482 cyclophosphamide affects response to substance ISO RGD:737172 6480464 NID1 protein affects the susceptibility to Cyclophosphamide CTD PMID:16217747 cyclosporin A decreases expression ISO RGD:737172 6480464 Cyclosporine results in decreased expression of NID1 mRNA CTD PMID:20106945 , PMID:25562108 dexamethasone increases expression ISO RGD:737172 6480464 Dexamethasone results in increased expression of NID1 mRNA CTD PMID:25047013 dibutyl phthalate increases expression ISO RGD:737173 6480464 Dibutyl Phthalate results in increased expression of NID1 mRNA CTD PMID:21266533 dicrotophos increases expression ISO RGD:737172 6480464 dicrotophos results in increased expression of NID1 mRNA CTD PMID:28302478 dioxygen increases expression ISO RGD:737173 6480464 Oxygen deficiency results in increased expression of NID1 mRNA CTD PMID:24205000 diuron decreases expression EXP 6480464 Diuron results in decreased expression of NID1 mRNA CTD PMID:25152437 diuron increases expression EXP 6480464 Diuron results in increased expression of NID1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:737172 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:737172 6480464 Doxorubicin results in decreased expression of NID1 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of NID1 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:737172 6480464 entinostat results in increased expression of NID1 mRNA CTD PMID:27188386 ethanol increases expression ISO RGD:737173 6480464 Ethanol results in increased expression of NID1 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:737172 6480464 Ethyl Methanesulfonate results in increased expression of NID1 mRNA CTD PMID:23649840 folic acid multiple interactions ISO RGD:737173 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NID1 mRNA CTD PMID:20938992 formaldehyde increases expression ISO RGD:737172 6480464 Formaldehyde results in increased expression of NID1 mRNA CTD PMID:23649840 hydroquinone decreases expression ISO RGD:737172 6480464 hydroquinone results in decreased expression of NID1 mRNA CTD PMID:31256213 irinotecan increases expression ISO RGD:737172 6480464 Irinotecan metabolite results in increased expression of NID1 mRNA, Irinotecan results in increased expression of NID1 mRNA CTD PMID:15956246 L-methionine multiple interactions ISO RGD:737173 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NID1 mRNA CTD PMID:20938992 levonorgestrel multiple interactions ISO RGD:737172 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NID1 mRNA CTD PMID:19074003 lipopolysaccharide increases expression ISO RGD:737173 6480464 Lipopolysaccharides results in increased expression of NID1 mRNA CTD PMID:27339419 methotrexate increases expression ISO RGD:737172 6480464 Methotrexate results in increased expression of NID1 mRNA CTD PMID:24449571 methyl methanesulfonate increases expression ISO RGD:737172 6480464 Methyl Methanesulfonate results in increased expression of NID1 mRNA CTD PMID:23649840 N-methyl-4-phenylpyridinium increases expression ISO RGD:737172 6480464 1-Methyl-4-phenylpyridinium results in increased expression of NID1 mRNA CTD PMID:24810058 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of NID1 mRNA CTD PMID:19638242 N-nitrosodiethylamine increases expression ISO RGD:737173 6480464 Diethylnitrosamine results in increased expression of NID1 mRNA CTD PMID:24535843 N-nitrosodiethylamine multiple interactions ISO RGD:737173 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of NID1 mRNA CTD PMID:24535843 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of NID1 mRNA CTD PMID:25380136 nickel sulfate decreases expression ISO RGD:737173 6480464 nickel sulfate results in decreased expression of NID1 mRNA CTD PMID:16166746 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of NID1 mRNA CTD PMID:24136188 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of NID1 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of NID1 mRNA CTD PMID:25729387 p-toluidine decreases expression EXP 6480464 4-toluidine results in decreased expression of NID1 mRNA CTD PMID:27638505 paracetamol increases expression ISO RGD:737173 6480464 Acetaminophen results in increased expression of NID1 mRNA CTD PMID:11264010 , PMID:29246445 paracetamol multiple interactions ISO RGD:737173 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of NID1 mRNA] CTD PMID:29246445 paracetamol decreases expression ISO RGD:737172 6480464 Acetaminophen results in decreased expression of NID1 mRNA CTD PMID:21420995 paracetamol affects expression ISO RGD:737173 6480464 Acetaminophen affects the expression of NID1 mRNA CTD PMID:17562736 pentanal increases expression ISO RGD:737172 6480464 pentanal results in increased expression of NID1 mRNA CTD PMID:26079696 perfluorooctanoic acid decreases expression ISO RGD:737172 6480464 perfluorooctanoic acid results in decreased expression of NID1 protein CTD PMID:26879310 phenobarbital increases expression ISO RGD:737173 6480464 Phenobarbital results in increased expression of NID1 mRNA CTD PMID:19482888 phenobarbital affects expression ISO RGD:737173 6480464 Phenobarbital affects the expression of NID1 mRNA CTD PMID:23091169 phenobarbital multiple interactions ISO RGD:737173 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of NID1 mRNA, NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NID1 mRNA] CTD PMID:19482888 , PMID:24535843 progesterone decreases expression ISO RGD:737173 6480464 Progesterone results in decreased expression of NID1 mRNA CTD PMID:19693291 retinyl acetate increases expression ISO RGD:737173 6480464 retinol acetate results in increased expression of NID1 mRNA CTD PMID:16772331 Salinomycin decreases expression ISO RGD:737172 6480464 salinomycin results in decreased expression of NID1 mRNA CTD PMID:19682730 SB 431542 multiple interactions ISO RGD:737172 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of NID1 mRNA CTD PMID:22431001 sodium arsenite affects expression ISO RGD:737173 6480464 sodium arsenite affects the expression of NID1 mRNA CTD PMID:16507464 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of NID1 protein CTD PMID:29459688 sodium fluoride decreases expression ISO RGD:737173 6480464 Sodium Fluoride results in decreased expression of NID1 protein CTD PMID:28918527 Soman increases expression EXP 6480464 Soman results in increased expression of NID1 mRNA CTD PMID:19281266 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of NID1 mRNA CTD PMID:21515302 testosterone decreases expression ISO RGD:737173 6480464 Testosterone results in decreased expression of NID1 mRNA CTD PMID:19693291 , PMID:20403060 testosterone undecanoate multiple interactions ISO RGD:737172 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NID1 mRNA CTD PMID:19074003 tetrachloroethene increases expression ISO RGD:737173 6480464 Tetrachloroethylene results in increased expression of NID1 mRNA CTD PMID:28973375 tetrachloromethane increases expression ISO RGD:737173 6480464 Carbon Tetrachloride results in increased expression of NID1 mRNA CTD PMID:27339419 , PMID:29987408 toluene increases expression EXP 6480464 Toluene results in increased expression of NID1 mRNA CTD PMID:22967744 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of NID1 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of NID1 mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:737172 6480464 trichostatin A results in increased expression of NID1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:737172 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NID1 mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:737172 6480464 Triclosan results in decreased expression of NID1 mRNA CTD PMID:30510588 troglitazone increases expression ISO RGD:737173 6480464 troglitazone results in increased expression of NID1 mRNA CTD PMID:28973697 valproic acid affects expression ISO RGD:737172 6480464 Valproic Acid affects the expression of NID1 mRNA CTD PMID:25979313 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of NID1 mRNA CTD PMID:29427782 valproic acid multiple interactions ISO RGD:737172 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NID1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:737172 6480464 Valproic Acid results in increased expression of NID1 mRNA CTD PMID:24383497 more ... valproic acid increases expression ISO RGD:737173 6480464 Valproic Acid results in increased expression of NID1 mRNA CTD PMID:24896083 vancomycin decreases expression ISO RGD:737173 6480464 Vancomycin results in decreased expression of NID1 mRNA CTD PMID:18930951 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of NID1 mRNA CTD PMID:20566332 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of NID1 mRNA CTD PMID:19015723
Biological Process cell-matrix adhesion ISO RGD:737173 1624291 (MGI:MGI:2387502, PMID:12243745) RGD MGI:MGI:2387502 , PMID:12243745 cell-matrix adhesion IEA InterPro:IPR003886 1600115 GO_REF:0000002 InterPro GO_REF:0000002 cell-matrix adhesion IEA UniProtKB:P10493 , ensembl:ENSMUSP000000055321600115 GO_REF:0000107 Ensembl GO_REF:0000107 extracellular matrix organization ISO RGD:737173 1624291 (MGI:MGI:3807344, PMID:18757743) RGD MGI:MGI:3807344 , PMID:18757743 glomerular basement membrane development ISO RGD:737173 1624291 MGI:MGI:2682959 (MGI:MGI:2680880 , PMID:14566019) RGD MGI:MGI:2680880 , PMID:14566019 glomerular basement membrane development IEA UniProtKB:P10493 , ensembl:ENSMUSP000000055321600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of cell-substrate adhesion ISO RGD:737173 1624291 (MGI:MGI:3807344, PMID:18757743) RGD MGI:MGI:3807344 , PMID:18757743 positive regulation of cell-substrate adhesion IEA UniProtKB:P10493 , ensembl:ENSMUSP000000055321600115 GO_REF:0000107 Ensembl GO_REF:0000107 Cellular Component basement membrane ISO RGD:737172 1624291 (PMID:22952693) RGD PMID:22952693 basement membrane ISO RGD:737173 1624291 UniProtKB:P02462 more ... RGD MGI:MGI:1928005 more ... basement membrane IEA UniProtKB-SubCell:SL-0025 1600115 GO_REF:0000039 UniProt GO_REF:0000039 basement membrane IEA UniProtKB:P14543 , ensembl:ENSP000002641871600115 GO_REF:0000107 Ensembl GO_REF:0000107 basement membrane IEA UniProtKB:P10493 , ensembl:ENSMUSP000000055321600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell periphery ISO RGD:737173 1624291 (MGI:MGI:3850905, PMID:19295126) RGD MGI:MGI:3850905 , PMID:19295126 cell periphery IEA UniProtKB:P10493 , ensembl:ENSMUSP000000055321600115 GO_REF:0000107 Ensembl GO_REF:0000107 extracellular matrix ISO RGD:737173 1624291 (MGI:MGI:3624079, PMID:16618944) RGD MGI:MGI:3624079 , PMID:16618944 Molecular Function calcium ion binding IEA InterPro:IPR001881 , InterPro:IPR018097 1600115 GO_REF:0000002 InterPro GO_REF:0000002 collagen binding ISO RGD:737173 1624291 (MGI:MGI:3721838, PMID:17517882) RGD MGI:MGI:3721838 , PMID:17517882 collagen binding IEA UniProtKB:P14543 , ensembl:ENSP000002641871600115 GO_REF:0000107 Ensembl GO_REF:0000107 collagen binding IEA UniProtKB:P10493 , ensembl:ENSMUSP000000055321600115 GO_REF:0000107 Ensembl GO_REF:0000107 collagen binding ISO RGD:737172 1624291 (PMID:22952693) RGD PMID:22952693 extracellular matrix binding ISO RGD:737173 1624291 (MGI:MGI:3807344, PMID:18757743) RGD MGI:MGI:3807344 , PMID:18757743 laminin binding ISO RGD:737172 1624291 (PMID:22952693) RGD PMID:22952693 laminin-1 binding ISO RGD:737173 1624291 (MGI:MGI:3721838, PMID:17517882) RGD MGI:MGI:3721838 , PMID:17517882 laminin-1 binding IEA UniProtKB:P10493 , ensembl:ENSMUSP000000055321600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein binding IPI UniProtKB:Q91ZV7 8554764 PMID:16574105 IntAct protein binding ISO RGD:737173 1624291 UniProtKB:P02468 more ... RGD MGI:MGI:2156955 more ... proteoglycan binding ISO RGD:737172 1624291 UniProtKB:Q05793 (PMID:22952693) RGD PMID:22952693 proteoglycan binding IEA UniProtKB:P14543 , ensembl:ENSP000002641871600115 GO_REF:0000107 Ensembl GO_REF:0000107
Gene-Chemical Interaction Annotations
